Learn about collaborative initiatives to tackle the most pressing challenges facing clinical development. Executive leadership from the organizations driving clinical research quality improvement through process and technology change initiatives will discuss initiatives ranging from investigator qualification and GCP mutual recognition to quality by design, mobile clinical trials, and more.
- Dr. Pamela Tenaerts, MD, MBA, Executive Director, Clinical Trials Transformation Initiative
- Patricia Leuchten, President and CEO, The Avoca Group
- Douglas Peddicord, Ph.D., Executive Director, Association of Clinical Research Organizations
- Andy Lee, SVP, Head Global Clinical TrialOperations, Merck Inc. and Treasurer, TransCelerate
Continuing education units/contact hours are NOT provided for this session.